Invex Therapeutics Revenue

Invex Therapeutics had revenue of 229.08K AUD in the twelve months ending December 31, 2025, down -81.10% year-over-year. In the fiscal year ending June 30, 2025, Invex Therapeutics had annual revenue of 229.08K, down -81.10%.

Revenue

229.08K

Revenue Growth

-81.10%

P/S Ratio

36.09

Revenue / Employee

n/a

Employees

n/a

Market Cap

8.27M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	229.08K	-983.17K	-81.10%
Jun 30, 2024	1.21M	753.17K	164.06%
Jun 30, 2023	459.09K	276.83K	151.90%
Jun 30, 2022	182.25K	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	Pro	Pro	Pro
Jun 30, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chimeric Therapeutics	9.75M
Immuron	7.48M
Tissue Repair	3.38M
Biotron	-868.00
Bio-Gene Technology	390.63K
AdAlta	608.07K
Vectus Biosystems	89.96K
Zelira Therapeutics	656.00

Revenue Rankings